Should you invest in emerging markets?
Emerging markets offer strong, long-term growth and excellent value, says Rupert Hargreaves
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Twice daily
MoneyWeek
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Four times a week
Look After My Bills
Sign up to our free money-saving newsletter, filled with the latest news and expert advice to help you find the best tips and deals for managing your bills. Start saving today!
Emerging-market (EM) equities have struggled to get the attention of investors over the past five years. Since 2020, the MSCI Emerging Markets Index has underperformed the MSCI Developed Market Index by a total of 45%, according to JPMorgan.
Virtually all of this gap can be attributed to the outperformance of the US and the underperformance of China. Chinese equities comprise 28% of the MSCI EM index, followed by Taiwan at 20%, although half of that is accounted for by Taiwan Semiconductor, which has a 10.5% weighting. TSMC is by far the largest holding and is more than twice the size of the next largest, China’s Tencent at 4.5% of the index.
Emerging-market stocks are cheap
The outperformance of the US equity market compared with the rest of the world since 2020 has driven relative EM valuations to multi-decade lows. The MSCI Emerging Market’s forward price/earnings (p/e) ratio now stands at a 40% discount to developed-market peers, the biggest differential since 2006. On a price-to-book value basis, EMs are trading at a gap to developed markets not seen since 2001. That is just the headline figure; the valuation dispersion among EM equities is enormous.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
According to JPMorgan’s analysis, Chile, Turkey, Poland, Brazil and Mexico are all trading at discounts of 30% or more to their two-decade average on a forward p/e basis. Korea and South Africa are trading at discounts of 20% or more. On the other hand, Taiwan, Thailand and India are the most overvalued markets. These markets are trading at premiums to their 20-year average of between 21% to 28% on a forward p/e basis, although for Taiwan, the figures are skewed by TSMC.
Despite these low valuations, emerging economies as a group are expected to grow faster than their larger, developed peers in 2025. Analysis conducted by specialist EM fund manager Ashmore suggests they will grow 3.9% as a group in 2025, more than double the 1.5% predicted for developed markets.
Asian economies will lead the charge, with growth of 4.4% pencilled in for 2025. Outside Asia, the Middle Eastern oil-power economies are expected to underpin growth in the Middle East/Africa region to 3.6% in 2025. Eastern European economies are expected to chalk up growth of 3%.
These figures are subject to a high degree of uncertainty, as we have yet to see how Donald Trump’s tariffs on key US trading partners influence trade. Earlier this month Trump imposed tariffs of 25% on all goods from Canada and Mexico (excluding oil from Canada, which will be hit with a tariff of 10%) and tariffs of 10% on China. At the time of writing, however, he has paused the levies on Canada and Mexico by a month.
Mexico has the most to lose. Exports to the US accounted for 25.2% of its GDP as of March 2024, making it the most exposed to any protectionist trade policies. China is actually one of the least exposed countries. According to Ashmore, just 2.7% of China’s GDP is tied to US exports. That’s not to say tariffs won’t have much of an impact on China’s economy. Any trade restrictions are likely to be deflationary and could drive the country’s policymakers to monetary stimulus or fiscal support to cushion the economic blow. The spillover effects of these policies could be a net positive for other emerging markets if the country unleashes its massive multi-trillion dollar fiscal surplus to save the economy.
The ultimate impact of a global trade war is difficult to determine, but that doesn’t mean investors should give up on emerging markets. In fact, tariffs are likely to hit the pockets of US consumers more than anything else, and in recent years many countries have made huge progress in shifting their supply chains to deal with more protectionist policies.
In addition, there is more to the world of emerging markets than the traditional plays such as China, Mexico and Taiwan. Regions such as Poland, Turkey and South Africa are likely to escape the worst of the trade war and could even benefit as supply chains are rerouted. They also look incredibly cheap by historical standards.
These factors, coupled with the fact that US equities are currently priced for a Goldilocks environment, imply that adding historically cheap EM stocks to a portfolio and reducing exposure to expensive US equities could make sense.
Are active funds better for investing in emerging markets?
When it comes to investing in EMs, active funds are usually the better choice. While passive funds are usually the best way for investors to build exposure to global markets, EMs tend to be less efficient, so there are more opportunities for outperformance with active fund management.
One example is the Ashoka WhiteOak Emerging Markets Trust (LSE: AWEM), which makes use of a team of in-country experts to pick stocks, which has helped it outperform. The trust offers an annual redemption facility for investors. The nature of EMs also means that investment trusts are often the best vehicle for investors to build exposure. The closed-ended nature of trusts means they can invest in illiquid securities, and EM exchanges are often far less liquid than their developed counterparts.
The JPMorgan Emerging Markets Trust (LSE: JMG) is another broad play on these fast-growing, undervalued markets. We also like the Templeton Emerging Markets Investment Trust (LSE: TEM). Also worthy of further research is the Utilico Emerging Markets Trust (LSE: UEM), which, uniquely in the sector, focuses on infrastructure and utilities in developing countries.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

Rupert is the former deputy digital editor of MoneyWeek. He's an active investor and has always been fascinated by the world of business and investing. His style has been heavily influenced by US investors Warren Buffett and Philip Carret. He is always looking for high-quality growth opportunities trading at a reasonable price, preferring cash generative businesses with strong balance sheets over blue-sky growth stocks.
Rupert has written for many UK and international publications including the Motley Fool, Gurufocus and ValueWalk, aimed at a range of readers; from the first timers to experienced high-net-worth individuals. Rupert has also founded and managed several businesses, including the New York-based hedge fund newsletter, Hidden Value Stocks. He has written over 20 ebooks and appeared as an expert commentator on the BBC World Service.
-
How a ‘great view’ from your home can boost its value by 35%A house that comes with a picturesque backdrop could add tens of thousands of pounds to its asking price – but how does each region compare?
-
What is a care fees annuity and how much does it cost?How we will be cared for in our later years – and how much we are willing to pay for it – are conversations best had as early as possible. One option to cover the cost is a care fees annuity. We look at the pros and cons.
-
Three key winners from the AI boom and beyondJames Harries of the Trojan Global Income Fund picks three promising stocks that transcend the hype of the AI boom
-
RTX Corporation is a strong player in a growth marketRTX Corporation’s order backlog means investors can look forward to years of rising profits
-
Profit from MSCI – the backbone of financeAs an index provider, MSCI is a key part of the global financial system. Its shares look cheap
-
'AI is the real deal – it will change our world in more ways than we can imagine'Interview Rob Arnott of Research Affiliates talks to Andrew Van Sickle about the AI bubble, the impact of tariffs on inflation and the outlook for gold and China
-
Should investors join the rush for venture-capital trusts?Opinion Investors hoping to buy into venture-capital trusts before the end of the tax year may need to move quickly, says David Prosser
-
Food and drinks giants seek an image makeover – here's what they're doingThe global food and drink industry is having to change pace to retain its famous appeal for defensive investors. Who will be the winners?
-
Barings Emerging Europe trust bounces back from Russia woesBarings Emerging Europe trust has added the Middle East and Africa to its mandate, delivering a strong recovery, says Max King
-
How a dovish Federal Reserve could affect youTrump’s pick for the US Federal Reserve is not so much of a yes-man as his rival, but interest rates will still come down quickly, says Cris Sholto Heaton